226 related articles for article (PubMed ID: 36293314)
1. An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains.
Troudi A; Bolla JM; Klibi N; Brunel JM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293314
[TBL] [Abstract][Full Text] [Related]
2. Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants.
Yu B; Roy Choudhury M; Yang X; Benoit SL; Womack E; Van Mouwerik Lyles K; Acharya A; Kumar A; Yang C; Pavlova A; Zhu M; Yuan Z; Gumbart JC; Boykin DW; Maier RJ; Eichenbaum Z; Wang B
ACS Infect Dis; 2022 Aug; 8(8):1491-1508. PubMed ID: 35801980
[TBL] [Abstract][Full Text] [Related]
3. Simple Dipyrrin Analogues of Prodigiosin for Use as Colistin Adjuvants.
Siwawannapong K; Nemeth AM; Melander RJ; Rong J; Davis JR; Taniguchi M; Carpenter ME; Lindsey JS; Melander C
ChemMedChem; 2022 Aug; 17(16):e202200286. PubMed ID: 35704751
[TBL] [Abstract][Full Text] [Related]
4. Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria.
Mahdavi M; Findlay BL
Bioorg Med Chem; 2024 Jan; 97():117541. PubMed ID: 38096681
[TBL] [Abstract][Full Text] [Related]
5. The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?
Melander RJ; Melander C
ACS Infect Dis; 2017 Aug; 3(8):559-563. PubMed ID: 28548487
[TBL] [Abstract][Full Text] [Related]
6. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
Elife; 2022 Jan; 11():. PubMed ID: 35025730
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens.
Myers AG; Clark RB
Acc Chem Res; 2021 Apr; 54(7):1635-1645. PubMed ID: 33691070
[TBL] [Abstract][Full Text] [Related]
8. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine.
Liu Y; Tong Z; Shi J; Jia Y; Deng T; Wang Z
Commun Biol; 2021 Nov; 4(1):1328. PubMed ID: 34824393
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a new aerosol antibiotic/adjuvant combination for the treatment of P. aeruginosa lung infections.
Douafer H; Andrieu V; Wafo E; Brunel JM
Int J Pharm; 2020 Aug; 586():119548. PubMed ID: 32565286
[TBL] [Abstract][Full Text] [Related]
10. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule Potentiation of Gram-Positive Selective Antibiotics against
Martin SE; Melander RJ; Brackett CM; Scott AJ; Chandler CE; Nguyen CM; Minrovic BM; Harrill SE; Ernst RK; Manoil C; Melander C
ACS Infect Dis; 2019 Jul; 5(7):1223-1230. PubMed ID: 31002491
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
Liu Y; Li R; Xiao X; Wang Z
Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 2-Aminobenzimidazole Scaffold that Potentiates Gram-Positive Selective Antibiotics Against Gram-Negative Bacteria.
Nemeth AM; Young MM; Melander RJ; Smith RD; Ernst RK; Melander C
Chembiochem; 2024 Apr; 25(8):e202400127. PubMed ID: 38451872
[TBL] [Abstract][Full Text] [Related]
14. Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.
Deng T; Jia Y; Tong Z; Shi J; Wang Z; Liu Y
Microbiol Spectr; 2022 Feb; 10(1):e0157821. PubMed ID: 35138168
[TBL] [Abstract][Full Text] [Related]
15. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
Peric M; Browne FA; Jacobs MR; Appelbaum PC
Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
[TBL] [Abstract][Full Text] [Related]
16. Scope and Limitations of Exploiting the Ability of the Chemosensitizer NV716 to Enhance the Activity of Tetracycline Derivatives against
Draveny M; Rose C; Pinet A; Ferrié L; Figadère B; Brunel JM; Masi M
Molecules; 2023 May; 28(11):. PubMed ID: 37298737
[TBL] [Abstract][Full Text] [Related]
17. Small-Molecular Adjuvants with Weak Membrane Perturbation Potentiate Antibiotics against Gram-Negative Superbugs.
Dhanda G; Mukherjee R; Basak D; Haldar J
ACS Infect Dis; 2022 May; 8(5):1086-1097. PubMed ID: 35404568
[TBL] [Abstract][Full Text] [Related]
18. Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline.
Wang Y; Su J; Zhou Z; Yang J; Liu W; Zhang Y; Zhang P; Guo T; Li G
Microbiol Spectr; 2023 Jun; 11(3):e0470222. PubMed ID: 37070985
[TBL] [Abstract][Full Text] [Related]
19. New Polyaminoisoprenyl Antibiotics Enhancers against Two Multidrug-Resistant Gram-Negative Bacteria from
Lieutaud A; Pieri C; Bolla JM; Brunel JM
J Med Chem; 2020 Sep; 63(18):10496-10508. PubMed ID: 32840108
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
